|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Institute on Drug Abuse (NIDA) Washington DC VA Medical Center Home |
|---|---|
| Information provided by: | National Institute on Drug Abuse (NIDA) |
| ClinicalTrials.gov Identifier: | NCT00000335 |
Purpose
The purpose of this study is to determine if hyperactivity accompanies abrupt opiate withdrawal in heroin addicts, to determine if computerized solid state activity monitors are capable of quantifying hyperactivity, and to quantify the physical and affective symptoms occurring during abrupt withdrawal in heroin addicts and morphine's capacity to alleviate these symptoms.
| Condition | Intervention | Phase |
|---|---|---|
|
Opioid-Related Disorders |
Drug: Morphine |
Phase II |
| Study Type: | Interventional |
| Study Design: | Treatment |
| Official Title: | Activity Monitoring Assessment of Opiate Withdrawal |
Eligibility| Ages Eligible for Study: | 21 Years to 55 Years |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Please contact site for information.
Contacts and Locations| United States, District of Columbia | |
| Washington DC VA | |
| Washington, District of Columbia, United States, 20422 | |
| Principal Investigator: | Steven Deutsch, M.D. | Washington DC VA |
More Information
| Study ID Numbers: | NIDA-3-0009-4, Y01-3-0009-4 |
| Study First Received: | September 20, 1999 |
| Last Updated: | August 16, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000335 |
| Health Authority: | United States: Federal Government |
|
Morphine Mental Disorders Substance-Related Disorders Disorders of Environmental Origin Opioid-Related Disorders |
